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Background: Antibiotics in neurosurgery are used for prophylaxis and treatment of already established infection.  
Guidelines state that prophylactic antibiotics should be given for up to 24 hours. For treatment of already established 
infections, empiric therapy with intravenous antibiotics for four to eight weeks is indicated. Studies have shown no 
distinction between antibiotic use for prophylaxis and treatment of established infection in neurosurgery.  
Objectives: To identify antibiotic use patterns and medication errors and their association with development of 
surgical site infections.  
Methods: A prospective cohort study involving adult neurosurgical patients was carried out at Kenyatta National 
Hospital, between April 2015 and July 2015. Patient demographic data as well as data on surgical procedures carried 
out, antibiotics used and medication errors was collected. Descriptive data analysis was done for all variables. To test 
for association between antibiotic use patterns and development of surgical site infections, the Fischer exact Chi 
square test was used. 
Results: Out of the 84 participants recruited in the study, 87.2% (n=68) used antibiotics. Ceftriaxone was the most 
commonly used (63.7%, n= 44), followed by metronidazole (40.4%, n=23).  Medication errors that were noted 
involved inappropriate choice and use of antibiotics. There was no distinction between use of antibiotics for 
prophylaxis and treatment of infection. There was no statistically significant association between patterns of 
antibiotic use and development of surgical site infection. 
Conclusion: Antibiotic use patterns do not affect the incidence of neurosurgical site infections. Prescribing errors of 
various types were prominent. An antibiotic use protocol should guide antimicrobial selection and use in 
neurosurgery.  
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1. Introduction 
Antibiotic use in neurosurgery serves the purposes of 
prophylaxis and treatment of already established 
infections. Antimicrobial prophylaxis should not be done 
for more than 24 hours. The choice of antibiotic for 
prophylaxis should be based on the knowledge of 
causative organisms at the incision site, antimicrobial 
susceptibility and resistance patterns at the unit, safety 
and cost effectiveness of the antibiotic (ASHP 
Therapeutic Guidelines, 2016). Guidelines exist on the 
presumptive treatment of intracranial infections. For 
brain abscesses, treatment with intravenous antibiotics 
is indicated for a period of 4 to 8 weeks, depending on 
the response of the patient. The long duration of 
treatment is required because of the long time required 
for the brain tissue to repair and close the abscess space. 
The recommended antibiotics should adequately cross 
the blood brain barrier and achieve adequate 
concentrations in the brain (Brook, 2015).  
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Despite existing guidelines, common practice in 
neurosurgery across studies shows that antibiotics are 
used to cover for surgical site infections (SSIs) pre and 
postoperatively (Jiang et al, 2016; Ha et al, 2012). This 
has led to prolonged prophylaxis, which in turn increases 
the risk of surgical site infections (Bozkurt et al, 2013; Ha 
et al, 2012). This is not uncommon in our set up, where 
antibiotics are generally used with no distinction 
between antimicrobial prophylaxis and treatment of 
already established infections. Lack of antimicrobial use 
protocols has further compounded the problem.  
Our study set out to establish the extent of this problem 
at the neurosurgical unit of Kenyatta National Hospital. 
The main objective was to identify antibiotic use 
patterns and their association with development of 
surgical site infections as well as identify medication 
errors in antibiotic use. 
2. Methodology 
2.1 Study Design and Population 
We conducted a prospective cohort which followed up 
trauma surgical patients admitted in the Neurosurgical 
wards of KNH between April 2015 and July 2015 for 
antibiotic use and development of surgical site 
infections.  
2.2 Inclusion and Exclusion Criteria 
Adult patients over 18 years old, who sustained 
traumatic injuries, were admitted at the neurosurgical 
unit for elective and emergency neurosurgery in the 
study period were included.  
Patients who underwent neurosurgery for reasons other 
than trauma were excluded.  
2.3 Sampling and Participant Recruitment  
The sample size was calculated using the formula for 
prospective incidence studies (Daniel, 2010).  
A study carried out by Njiru et al, (2015) reported an 
incidence of SSIs of 7.5% in patients who were 
undergoing elective craniotomy at the neurosurgical unit 
of Kenyatta National Hospital. Using this incidence and 
the estimated patient population of Kenyatta National 
Hospital to be 1800, a sample size of 100 patients was 
estimated.  
2.4 Sampling 
The investigator perused through patient files in the 
neurosurgical ward to identify eligible patients. 
Universal sampling was used to include all patients who 
met the inclusion criteria.  
2.5 Data Collection  
Patients were followed up in the ward daily and the 
following information abstracted and recorded in 
predesigned data collection forms:  patient biodata, 
surgical procedure, antibiotics administered and the 
patterns of use in terms of dosing, frequency and 
duration of administration; medication errors, and 
development of surgical site infections.  
2.6 Data Analysis  
All variables were subjected to descriptive analysis. The 
Fischer exact Chi Square test was used to test for 
association between antibiotic use patterns and 
development of surgical site infections. Data analysis 
was done using STATA version 13 software. The level of 
significance was set at 0.05. 
2.7 Ethical Considerations  
Approval to carry out the study was sought from the 
University of Nairobi/ Kenyatta National Hospital 
Research and Ethics Committee, approval number 
P76/02/2014. Informed consent was sought from 
patients and/or their caregivers before enrolment into 
the study. All the patient information was treated with 
confidentiality. Serial numbers were used instead of 
patient names and admission numbers. All the data was 
password protected and accessible only to the 
investigator and data analyst. 
3.  Results  
The study recruited 84 adult patients 18 years and older, 
who sustained neurotrauma through road traffic 
accidents, assault, falls and other unidentified forms of 
trauma.  
The males formed 93% of the study population (n=78) 
with the females being 7% (n=8) of the study population. 
The median age of the patients was 35 years. 
3.1 Prevalence and types of antibiotics used in 
surgical and non-surgical patients 
The total number of patients who were on antibiotics 
was 68 (87.2%). Of those who underwent surgery, 89.5% 
(n=51) used antibiotics. Ceftriaxone was the most 
commonly prescribed antibiotic (78.9%, n=45), followed 
by metronidazole, amoxicillin clavulanate, cefuroxime 
and meropenem (Figure 1). 
The number of antibiotics prescribed per patient varied 
between one and four. Those who were put on one 
antibiotic were 20.3%, (n=14) while 26.1% (n=18) 
received two antibiotics. Fourteen patients (20.3%) 
received three antibiotics while 5.8% (n=4) were on four 
antibiotics during the time of hospitalization. As the 
number of antibiotics used increased, the likelihood of 
development of infection increased, and this was 
statistically significant (p=0.015).  
3.2 Patterns of antibiotic prescription 
Thirty one patients had one ceftriaxone prescription. The 
daily defined dose for Ceftriaxone is 2g according to the 
WHO ATC DDD Classification, 2016.  
Slightly over half of the patients (54.8%) received the 
daily recommended dose of Ceftriaxone (2g), while 30% 
received more than the daily recommended dose of 
ceftriaxone (3-4g). 3.2% of the patients on ceftriaxone 
were on an unspecified dose.  
Twelve patients had a second prescription of ceftriaxone 
(17.4%).  For eleven of these patients (91.7%), the 
duration of use was not indicated. Of the patients on only 
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one prescription of ceftriaxone, 38.6% (n=17) developed 
surgical site infection, while for those on the second 
prescription, 91.7% (n=11) developed surgical site 
infection.   
Figure 1: Types of antibiotics used with or without surgery 
 
There was no statistically significant association 
between administration of the first prescription of 
ceftriaxone and development of surgical site infection 
(p=0.478). Similarly, there was no statistically significant 
association between the second prescription of 
ceftriaxone and development of surgical site infection 
(p=0.720).  
Metronidazole was used by 40.4% (n=23) of the patients 
who were on antibiotics, of which 87.0% (n=20) 
underwent surgery. All the patients received 500 mg of 
metronidazole 8 hourly. This translates to a daily dose of 
1.5g, which is the recommended daily dose for 
metronidazole (WHO ATC DDD). Of the patients on 
metronidazole who underwent surgery, 57.9% 
developed infection (n=11). There was no statistically 
significant association between metronidazole use and 
development of infection (p=0.121).  
Amoxicillin clavulanate was prescribed for 23 patients. 
Of these, 78.3% (n=18) underwent surgery. There was 
no statistically significant association between the dose 
(p=0.695), frequency (p=0.801) and duration of 
amoxicillin clavulanate use (p=0.770) and surgical 
procedure.  
According to the WHO ATC DDD Classification, the daily 
recommended dose for this drug is 1000mg of the 
amoxicillin component for the oral drug and 3g for the 
intravenous form. Only two patients were on the oral 
formulation while 19 were on the intravenous form. 
Assuming the two were on 1000mg of amoxicillin, it 
could imply that they exceeded the recommended dose 
two fold. This assumption of dose is made because the 
formulations available at the hospital contain 1000mg of 
amoxicillin. 
Ten patients who were on amoxicillin clavulanate 
developed surgical site infection. There was no 
statistically significant association between the route, 
dose, frequency and duration of use of the drug and 
development of surgical site infection.  
Eight patients received cefuroxime during the study 
period and 87.5% (n=7) of them underwent surgery. 
There was no statistically significant association 
between the cefuroxime use patterns and surgical 
procedure (p=0.450).  
The daily recommended dose for oral cefuroxime is 0.5g 
while that of the parenteral version is 3g. Only two 
patients were on oral cefuroxime while the rest were on 
an unspecified route of administration. Assuming two of 
those on oral cefuroxime were on 500mg, both given 
twice daily, it shows that they could have exceeded the 
dose by twice the recommended dose. Four of the 
patients who received cefuroxime (57.1%) developed 
surgical site infection. There was no statistically 
significant association between infection rates and the 
daily recommended dose of cefuroxime (p=0.714).  
Three patients were on meropenem and two of them 
underwent surgery. There was a statistically significant 
association between the frequency of administration of 
meropenem and surgical procedure (p=0.028), as well as 
the duration of use (p=0.068).The association between 
the use patterns of meropenem and development of 
infection was not statistically significant (p=0.103). 
3.3. Medication Errors in Antibiotic Use at the 
Neurosurgical Unit 
The most common medication errors in antibiotic use 
were prescribing errors.  According to the National co-
ordinating council for medication error reporting and 
prevention (NCC-MERP, 2001), prescribing errors can 
occur in form of: dose omission, improper dosage (under 
dose or overdose), wrong strength, wrong drug, wrong 
dosage form, wrong route of administration, wrong 
duration, inappropriate drug selection, lack of a clear 
purpose of a drug on a prescription and medication 
0
5
10
15
20
25
30
35
40
45
N
u
m
b
e
r 
o
f 
p
at
ie
n
ts
Type of antibiotic
No surgery
Surgery
 Opanga et al, Afr. J. Pharmacol. Ther. 2016. 5(4): 241-246 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
244 
prescribed to the wrong patients.  Several prescribing 
errors were recorded in this study.  
Prescribing in trade names  
Metronidazole (64.0%, n=23), Amoxicillin clavulanate 
(42.0%, n=21) and cefuroxime (16.0%, n=8) were 
prescribed in trade names (Flagyl, Augmentin and 
Power-cef respectively). Although this is not in itself a 
medication error, it could potentially lead to medication 
errors.  
Unspecified dose, route, frequency and duration of 
administration 
For most prescriptions, the dose, frequency and duration 
of administration was not specified. This could have led 
to errors in administration of the antibiotics. This is 
illustrated in Table 1. There were more medication 
errors among patients who underwent surgery 
compared to those who did not undergo surgery. 
Prolonged duration of administration  
Prolonged use of antibiotics was defined as antibiotics 
administered for more a period of 14 days and more. The 
caveat to this is that intracranial abscesses require to be 
treated with intravenous antibiotics for up to 4 weeks.  
Thirty five per cent of the patients (n=24) received 
antibiotics for a prolonged period, and they all developed 
surgical site infections (Table 2). 
 
       Table 1: Unspecified dose, route and frequency of administration of antibiotics 
Unspecified dose No Surgery (%) Surgery, n (%) 
Gentamicin qidx7days 0 (0.0%) 1(100.0%) 
Unspecified route No Surgery (%) Surgery, n (%) 
Metronidazole  3 (27.3%) 8(72.7%) 
Amoxicillin clavulanate 3(23.1%) 10 (76.9%) 
Cefuroxime  1 (16.7%) 5 (83.3%) 
Meropenem  1 (50.0%) 1 (50.0%) 
Gentamicin 0 (0.0%) 1(100.0%) 
Flucloxacillin 0(0.0%) 1(100.0%) 
Amikacin 0(0.0%) 1(100.0%) 
Unspecified frequency No Surgery (%) Surgery, n (%) 
Ceftriaxone    
Metronidazole  0(0.0%) 1(100.0%) 
Amoxicillin clavulanate 0(0.0%) 2(100.0%) 
Cefuroxime  
Meropenem 
0(0.0%) 
1 (100.0%) 
1 (100.0%) 
0(0.0%) 
Unspecified duration No Surgery, n (%) Surgery, n (%) 
Metronidazole  1(25.0%) 3 (75.0%) 
Amoxicillin clavulanate 0 (0.0%) 1 (100.0%) 
Cefuroxime  0 (0.0%) 1(100.0%) 
Meropenem  0 (0.0%) 1(100.0%) 
Flucloxacillin  1(100.0%) 0 (0.0%) 
Wrong dose 
Amikacin 50mg  
Abbreviations  
TEO 
 
0 (0.0%) 
 
1(100.0%) 
 
1(100.0%) 
 
0 (0.0%) 
 
Table 2: Number of patients who received antibiotics for a prolonged period  
 Ceftriaxone Metronidazole Coamoxiclav Cefuroxime Clindamycin Amikacin Meropenem 
14 days 12 3 2 1 1 - - 
21 days 1 2 - - - - - 
Indefinite - - - - - 1 1 
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Inappropriate combinations of antibiotics 
Inappropriate antibiotic combinations refer to a 
combination of two or more antibiotics from the same or 
related class, with the same antimicrobial spectrum. In 
this case, nineteen patients received inappropriate 
combinations of amoxicillin clavulanate and 
cephalosporins. The caveat to this observation is that the 
antibiotics could have been switched following poor 
clinical response or using culture and sensitivity reports.  
Inappropriate Antibiotic Selection  
Prescription of antibiotics was not based on any 
guidelines, evidence or antimicrobial susceptibility 
patterns for patients who underwent surgery as well as 
those who developed infection. A study done by Njiru et 
al, (2015) on antimicrobial resistance patterns in this 
neurosurgical unit reported high antimicrobial 
resistance patterns to commonly used antimicrobials.  
To illustrate this, we obtained resistance data from the 
said study, and using Staphylococcus aureus and 
Klebsiella as our reference organisms, we postulated that 
all patients on Amoxicillin clavulanate, cefuroxime and 
meropenem were unlikely to benefit from the antibiotics. 
Unclear Indication of prescription 
There was no clear indication for administering 
antibiotics, whether for prophylaxis or treatment. For 
purposes of discussion, we made an assumption that any 
antibiotic given for three days or less was given for 
prophylaxis and presumptive treatment was for those 
antibiotics that were given for more than three days.  
Inappropriate doses 
Using the WHO ATC DDD recommended daily doses of 
the major antibiotics, it was noted that some patients 
received more than the daily recommended doses of 
different antibiotics as shown in Table 3. 
   Table 3: Inappropriate dosing of antibiotics 
Drug  Daily recommended 
dose (DDD),mg 
No of patients on 
inappropriate dose 
Comments  
Ceftriaxone 2000 9 (20.0%) Overdose iv 
Amoxicillin Clavulanate 1000 oral, 3000 iv 2 (8.7%) Overdose on oral drug 
Cefuroxime  500 oral, 3000 iv 2 (25.0%) Overdose on oral drug 
 
4. Discussion 
Instances of irrational antimicrobial use were identified 
and prescribing errors were noted in this study. The 
irrational use stemmed from improper drug selection, 
unclear indication for antibiotic, inappropriate doses 
and wrong frequency and duration of administration of 
antimicrobials. This could be due to lack of antimicrobial 
use protocols and guidelines at Kenyatta National 
hospital. Prophylactic use of antibiotics may have been 
prolonged.  
 Our findings are similar to other studies in which 
antibiotic overuse and misuse was noted 
(Apostolopoulou et al, 2016; Testa et al, 2015; Sharma et 
al, 2012). As seen in our study, antibiotics to which the 
infecting microbes were resistant were still given despite 
the availability of resistance data. The same trend was 
reported in another study in which 94% of the patients 
received antibiotics despite antimicrobial resistance 
data.  
Antibiotic overuse has also been reported in another 
study where, all the patients received prophylaxis 
despite indication for only half of the patients 
(Apostolopoulou et al, 2016). Another study reports 
contrary results where there was underuse of antibiotics 
(Lundine et al, 2010).  
It was difficult to distinguish between antimicrobial 
prophylaxis and treatment regimens in our study. The 
same was also seen in other studies (Testa et al, 2015; 
Sharma 2012). The most common antibiotics used in our 
study were ceftriaxone, metronidazole, cefuroxime, 
Amoxicillin clavulanate and meropenem. Other studies 
also used similar drugs (Apostolopoulou et al, 2016; 
Hammad et al, 2013; Sharma et al, 2012).  Like in our 
study, combinations of antibiotics were used (Hawnet al, 
2013; Lundine et al, 2010). The use of some antibiotic 
combinations increased the risk of development of 
infections while some combinations reduced the risk 
(Hawn et al, 2013). Some combinations were deemed 
inappropriate just like in our study (Testa et al, 2015).  
Several studies reported prolonged antibiotic use 
beyond the treatment or prophylaxis duration just like in 
our study (Testa et al, 2015; Lorensia et al, 2012); yet this 
does not prevent the development of surgical site 
infections (Sharma et al, 2012).  
Similar studies reported that antimicrobial prophylaxis 
did not conform to guidelines or protocols, and there 
were variations in compliance regarding the choice of 
antibiotic, indication for prophylaxis, timing and 
discontinuation of prophylaxis (Gouveaet al, 2015; Testa 
et al, 2015). This is unlike in our study where there were 
no local protocols against which appropriate use of 
antibiotics could be compared. This calls for 
development of an antibiotic use protocol (Jiang et al, 
2016). The quality of antimicrobial prophylaxis can be 
improved through continuous training, compliance with 
available guidelines and supervision of the use of 
antibiotics (Bozkurt et al, 2013). 
5. Conclusion 
There was no clear distinction between antimicrobial 
prophylaxis and treatment of intracranial infections. 
Some antibiotics were used despite the fact that there 
was data on resistance to those antibiotics.    Guidelines 
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on antibiotics should be developed and adhered to, to 
reduce surgical site infections and improve outcomes of 
prophylaxis and treatment of neurosurgical site 
infections.  Clinical pharmacists should be incorporated 
in the neurosurgical team to guide antimicrobial use. 
Studies should be conducted to monitor the clinical 
effectiveness of antimicrobials alongside resistance 
patterns, to evaluate the overuse of antibiotics at the 
KNH neurosurgical unit, and to demonstrate the benefit 
of administration of antibiotics for shorter durations. 
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